Capital Markets Showcase

RNS Number : 0362P
Cambridge Cognition Holdings PLC
05 June 2020
 

5 June 2020

Cambridge Cognition Holdings Plc

(" Cambridge Cognition"   or the "Company")

 

Capital Markets Showcase

 

Cambridge Cognition Holdings plc (AIM: COG), which develops and markets digital solutions to assess brain health, is pleased to announce that it will be hosting a Capital Markets Showcase via Webex on 30 June 2020 at 10am.

 

The event will feature a series of presentations from Cambridge Cognition's management and senior leadership team focussing on the latest developments in the Company's product and technology portfolios.

 

To express interest in attending the event please email: zach.cohen@investor-focus.co.uk

 

No material new information or update on current trading will be disclosed at the event.

 

For further information, contact:

 

Cambridge Cognition Holdings PLC

Matthew Stork, Chief Executive Officer

Nick Walters, Chief Financial Officer

Tel: 012 2381 0700

press@camcog.com

finnCap Ltd (NOMAD and Joint Broker)

Geoff Nash / Simon Hicks

Alice Lane / Manasa Patil

Tel: 020 7220 0500

(Corporate Finance)

(Corporate Broking)

Dowgate Capital Limited (Joint Broker)

David Poutney / James Serjeant

Tel: 020 3903 7715

 

IFC Advisory Ltd (Financial PR and IR)

Tim Metcalfe / Graham Herring / Zach Cohen

Tel: 020 3934 6630

 

 

Notes to Editors

 

About Cambridge Cognition

 

Cambridge Cognition is a neuroscience technology company developing digital health products to better understand, detect and treat conditions affecting brain health. The company's software products assess cognitive health in patients worldwide to improve clinical trial outcomes, identify and stratify patients early and improve global efficiency in pharmaceutical and healthcare industries.

 

For further information visit www.cambridgecognition.com


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NRASSEFMLESSELM
UK 100

Latest directors dealings